Allegria therapeutics

MC Sciences

This biotechnology firm develops therapeutics targeting mast cells for patients with chronic inflammatory, respiratory, and dermatological conditions.

Excellergy Therapeutics

This biotechnology company develops trifunctional effector cell response inhibitors to treat patients with severe allergic diseases by removing bound antibodies from immune cells.

Alladapt Immunotherapeutics

This biopharmaceutical company develops oral immunotherapies for patients with single or multiple food allergies to reduce the severity of allergic reactions.

Third Harmonic Bio

This biopharmaceutical company develops oral small-molecule inhibitors for patients with mast-cell-mediated inflammatory diseases such as chronic urticaria and asthma.

Merida Biosciences

This company develops precision immunology therapies to treat patients suffering from autoimmune and allergic disorders.

Allergios

This company develops a cell-based diagnostic platform for clinicians to perform precise in vitro allergy tests using blood samples and automated visual analysis.

Tolergyx

This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.

Poplar Therapeutics

The company develops anti-immunoglobulin E antibody therapies to treat patients with food allergies and other atopic conditions.